These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17701513)

  • 1. Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff.
    Gjersing LR; Butler T; Caplehorn JR; Belcher JM; Matthews R
    Drug Alcohol Rev; 2007 Sep; 26(5):501-8. PubMed ID: 17701513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
    Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
    Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value for money in drug treatment: economic evaluation of prison methadone.
    Warren E; Viney R; Shearer J; Shanahan M; Wodak A; Dolan K
    Drug Alcohol Depend; 2006 Sep; 84(2):160-6. PubMed ID: 16487668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
    Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
    Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
    Winstock AR; Lea T; Sheridan J
    Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
    Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
    Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.
    Larney S; Toson B; Burns L; Dolan K
    Addiction; 2012 Feb; 107(2):372-80. PubMed ID: 21851442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acceptability of combined methadone-naloxone treatment: Consumer and provider views on the potential utility of methadone-naloxone.
    Shearer J; Mammen K; Bell J
    Drug Alcohol Rev; 2010 Mar; 29(2):138-43. PubMed ID: 20447220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.
    Lawrinson P; Roche A; Terao H; Le PP
    Drug Alcohol Rev; 2008 Jan; 27(1):47-53. PubMed ID: 18034381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to methadone treatment: harm reduction in theory and practice.
    Järvinen M
    Sociol Health Illn; 2008 Nov; 30(7):975-91. PubMed ID: 18564977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
    Marzo JN; Rotily M; Meroueh F; Varastet M; Hunault C; Obradovic I; Zin A
    Addiction; 2009 Jul; 104(7):1233-40. PubMed ID: 19426291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair analysis underestimates heroin use in prisoners.
    Shearer J; White B; Gilmour S; Wodak AD; Dolan KA
    Drug Alcohol Rev; 2006 Sep; 25(5):425-31. PubMed ID: 16939937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes towards prisoners, as reported by prison inmates, prison employees and college students.
    Kjelsberg E; Skoglund TH; Rustad AB
    BMC Public Health; 2007 May; 7():71. PubMed ID: 17480213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone maintenance treatment in prisons: The New South Wales Experience.
    Hall W; Ward J; Mattick R
    Drug Alcohol Rev; 1993; 12(2):193-203. PubMed ID: 16818329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive alcohol consumption is associated with reduced quality of life among methadone patients.
    Senbanjo R; Wolff K; Marshall J
    Addiction; 2007 Feb; 102(2):257-63. PubMed ID: 17222280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Knowledge and attitudes of prison staff towards HIV/AIDS: a European study].
    Rotily M; Prudhomme J; Pardal MS; Hariga F; Iandolo E; Papadourakis A; Moatti JP
    Sante Publique; 2001 Dec; 13(4):325-38. PubMed ID: 11963530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of substitution treatment in prisons--a literature review.
    Stallwitz A; Stöver H
    Int J Drug Policy; 2007 Dec; 18(6):464-74. PubMed ID: 18061872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.